Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

• Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

  2026 Nature Cancer article Computer Science AI in cancer detection Open access

  3

  citations
• BRAFV600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol

  2026 European Journal of Cancer article Medicine Glioma Diagnosis and Treatment Open access

  1

  citations
• TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas

  2026 Cell Reports Medicine article Medicine Glioma Diagnosis and Treatment Open access

  2

  citations
• The chromatin guardian ATRX is a strong prognostic biomarker in melanoma

  2025 Scientific Reports article Medicine Cutaneous Melanoma Detection and Management Open access

  0

  citations
• Histogram analysis of IVIM MRI for differentiating glioma IDH-1 status, grade, and Ki-67 expression: a comparison of bi-exponential models at multiple B-value

  2025 BMC Medical Imaging article Medicine MRI in cancer diagnosis Open access

  1

  citations
• TET CpG sequence context specific DNA demethylation shapes progression of IDH-mutant gliomas

  2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Glioma Diagnosis and Treatment Open access

  0

  citations
• Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

  2025 Neuro-Oncology article Medicine Glioma Diagnosis and Treatment Open access

  76

  citations
• Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

  2023 Clinical Cancer Research article Medicine Glioma Diagnosis and Treatment Open access

  27

  citations
• Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome

  2023 Blood Cancer Journal article Medicine Acute Myeloid Leukemia Research Open access

  37

  citations
• DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome—including in elderly patients

  2022 Acta Neuropathologica Communications article Medicine Glioma Diagnosis and Treatment Open access

  16

  citations
• Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial

  2022 Clinical Cancer Research article Medicine Glioma Diagnosis and Treatment Open access

  3

  citations
• DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome - including in elderly patients

  2022 medRxiv preprint Medicine Glioma Diagnosis and Treatment Open access

  2

  citations
• Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations

  2021 Acta Neuropathologica article Medicine Glioma Diagnosis and Treatment Open access

  61

  citations
• DNA methylation and survival differences associated with the type of IDH mutation in 1p/19q non-codeleted astrocytomas

  2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Glioma Diagnosis and Treatment Open access

  0

  citations
• Correction: A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival

  2020 British Journal of Cancer erratum Medicine Cancer Immunotherapy and Biomarkers Open access

  15

  citations
• A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival

  2020 British Journal of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

  40

  citations
• Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

  2020 Neuro-Oncology article Medicine Glioma Diagnosis and Treatment Open access cited by 1 patent

  1,195

  citations
• Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation

  2020 Journal of Neuro-Oncology article Medicine Telomeres, Telomerase, and Senescence Open access

  27

  citations

18 results